Premium
P4‐353: A PHASE 2 TRIAL OF THE EFFICACY AND SAFETY OF THE ALPHA7 AGONIST ABT‐126 AS AN ADD‐ON TREATMENT IN MILD‐TO‐MODERATE ALZHEIMER'S DEMENTIA
Author(s) -
Gault Laura M.,
Meier Andreas,
Florian Hana,
Gauthier Serge,
Lin Yunzhi,
Tang Qi,
Othman Ahmed
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.07.123
Subject(s) - donepezil , rivastigmine , placebo , medicine , dementia , adverse effect , randomized controlled trial , disease , alternative medicine , pathology